ESMO Targeted Anticancer Therapies Congress
3 March 20255 March 2025
Paris, FranceMarriott Rive Gauche Hotel
A multi-stakeholder forum bringing together researchers, industry partners, investors, and regulatory bodies related to the development of new anticancer drugs.
The ESMO TAT Congress is dedicated to improving the conduct of early phase clinical trials in oncology by providing the latest scientific breakthroughs as well as workshops and educational reviews on pre-clinical and early clinical data.
Latest Features
16 January 2025
16 January 2025
14 January 2025
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze